Research Center for Biology, Indonesian Institute of Sciences (LIPI), Cibinong, Indonesia.
Department of Biomedical Chemistry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Front Cell Infect Microbiol. 2021 Mar 9;11:639065. doi: 10.3389/fcimb.2021.639065. eCollection 2021.
Coenzyme A (CoA) is a well-known cofactor that plays an essential role in many metabolic reactions in all organisms. In , the most deadly among species that cause malaria, CoA and its biosynthetic pathway have been proven to be indispensable. The first and rate-limiting reaction in the CoA biosynthetic pathway is catalyzed by two putative pantothenate kinases (PanK1 and 2) in this parasite. Here we produced, purified, and biochemically characterized recombinant PanK1 for the first time. PanK1 showed activity using pantetheine besides pantothenate, as the primary substrate, indicating that CoA biosynthesis in the blood stage of can bypass pantothenate. We further developed a robust and reliable screening system to identify inhibitors using recombinant PanK1 and identified four PanK inhibitors from natural compounds.
辅酶 A (CoA) 是一种众所周知的辅因子,在所有生物的许多代谢反应中都发挥着重要作用。在导致疟疾的物种中,CoA 及其生物合成途径已被证明是必不可少的。CoA 生物合成途径中的第一个也是限速反应是由这种寄生虫中的两个假定的泛酸激酶 (PanK1 和 2) 催化的。在这里,我们首次生产、纯化和生化表征了重组 PanK1。PanK1 除了泛酸外,还以泛酰巯基乙胺作为主要底物表现出活性,表明疟原虫的血期 CoA 生物合成可以绕过泛酸。我们进一步开发了一种使用重组 PanK1 的强大且可靠的筛选系统来鉴定抑制剂,并从天然化合物中鉴定出四种 PanK 抑制剂。